Method of vitamin a or its derivatives isomerization

专利摘要:
1452012 Isomerizing vitamin A compounds F HOFFMANN-LA ROCHE & CO AG 20 Aug 1974 [21 Aug 1973] 36568/74 Heading C2V Vitamin A compounds and derivatives are isomerized by contact with palladium compounds other than palladium phthalocyanin and palladium compounds containing cyanide groups. The vitamin A compounds are those of formula where X is -CHO, -CH 2 OH, -COOH, -CH(R) 2 , -CH 2 OR<SP>1</SP>, -COOR<SP>2</SP>, -CONHR<SP>3</SP> or -CON(R<SP>3</SP>) 2 , R being an alkoxy group or two R's together are an alkylenedioxy group, R<SP>1</SP> being an alkanoyl or aroyl group, R<SP>2</SP> being an alkyl, aryl or aralkyl group and R<SP>3</SP> a hydrogen atom or an alkyl, aryl or aralkyl group. The isomerization may be carried out by heating in a solvent a mixture of the vitamin A compound and the palladium compound. In examples 9- cis, 11-cis and all-trans isomers of vitamin A acetate and aldehyde are isomerized with various palladium compounds.
公开号:SU731894A3
申请号:SU742056154
申请日:1974-08-20
公开日:1980-04-30
发明作者:Штоллер Хансюрг；Петер Вагнер Ханс
申请人:Ф. Хофманн-Ля Рош И Ко И Аг (Фирма)；
IPC主号:

专利说明:

This invention relates to a new process for the isomerization of compounds of the general formula I, cuts, cf, cn, cn, cn, cn, cn, cn. where X is OH, -CH, COOR; R n, Soonz; Rn, C2%, which refers to vitamin A and arc derivatives. Thus, in vitamin A (where X), as well as in its esters, all five conjugated double bonds are in the trans position. Complete trans-vitamin A, or its alkanoyl ester from all isomers, has the greatest biological effect and therefore is almost exclusively used for human nutrition and nutrition. Since vitamin A preparations are practically obtained synthetically, and since the known and used methods for their preparation do not give pure full trans-compounds, but only CMScHi of various isomers with more or less high content of full trans isomer, the problem The isomerization of various isomers into a complete trans compound is very important. There is a method of isomerization of cis isomers of compounds of formula 1 at 0 115 ° C using iodine and pyridine as a catalyst. The trans isomers are not high and reach 65; this is a disadvantage of this method. In addition, only 11-cis, 13-cis- and 11,13-di-cis-isomers are isomerized 1. In the photochemical method of isomerization of the cis-isomers of vitamin A or their derivatives using light with L 350 nm when using as light It is possible to obtain up to 90% trans-isomers of vitamin A derivatives. The disadvantage of this method is the use of pure cis-isomer as the source, as well as the insufficiently high yield of the desired product 2. The purpose of the invention is to increase the yield of the full trans-isomer. The goal is achieved by the described method of isomerization of vitamin A or its derivatives, the distinguishing feature of which is carrying out catalytic isomerization or the complete trans- or 9-cis or 11-cis isomer of vitamin A or its derivatives of the formula I in the presence of palladium compounds, which are usually salt or (Il) -Pd (IV) complexes with or without a carrier in the amount of Ojl-SO mol%, assuming the original, except phthalocyanine palladium and palladium compounds containing cyanide group B, an organic solvent, smoothly, in an aprotic polar or non-polar solvent with the addition of 10% water by volume without air access at 40-150 C.
Isomerization is preferably carried out on compounds of the general formula I, where R is - CHj OCOCH and R CHO.
This produces a mixture of isomers, which is about 40-80% in the case of vitamin A acetate {compound I, where R COOCH-j) consists of a complete trans compound, about 10-30% from a 9-cis compound and about 3% of 13-cis compound. In the case of an aldehyde of the formula I, where up to about 20% of the 13-cis compound. From this mixture, the complete trans compound can be separated by crystallization. From such a mixture, in the absence or only an insignificant content (up to 3-4%) of the 13-cis isomer, an almost pure complete trans compound is obtained by single crystallization.
The isomerization process can proceed both homogeneously and heterogeneously in a catalytic manner, both periodically and continuously.
Based on the invention, it is possible to increase the yield of complete trans compounds in the synthesis of vitamin A or the purity of the target product, since the 9-cis isomer present in the reaction mixtures in relatively large quantities can be isomerized to obtain a complete trans compound. syntheses that give the predominant share of the cis-isomer and are still not applicable in practice, since it is not possible to convert the P-dis-isomer into a complete trans-compound by methods known so far.
Example 1.7.5 mg (benzonitrile) 2 Pdce2. dissolved in 4.5 ml of benzene, 0.5 ml of acetonitrile and 8 ml of tripropylamine at room temperature. 240 ml of 9-cis-vitamin A acetate are added to 2 ml of this solution at room temperature in argon and with the exclusion of light, and the mixture is heated to 65 ° C for 2 hours. After cooling, to the reaction
the mixture was added 6 ml of acetonitrile and extracted 5 times using b ml of N-hexane. The combined hexane phases are evaporated at 40 s / 12 nm and at room temperature). 220 mg of a mixture of isomers containing 23% of 9-cis-vitamin A acetate and 71.5% of complete trans-vitamin A acetate are obtained. These 220 mg of a mixture of isomers are dissolved at room temperature in 400 ml of n-hexane. The solution is cooled
For 4 hours, complete transvitamin A acetate was seeded and seeded. The resulting crystals were isolated and washed with 80 ml of n-hexane (-20 ° C). After that, the crystals are dried for 1 h at room temperature under vacuum (10 mm). 110 mg of complete trans-vitamin A acetate are obtained with a purity of 99.6%.
Example 2. Analogously to example 1, a mixture of isomers containing 21.8% of 9-cis-vitamin A acetate and 73.4% is obtained from a mixture of 95% 11-cisvitamin A acetate and 5% 11,13-di-cis-Bitamine acetate. acetate full of vitamin A, from which practically pure acetate full of trans vitamin A crystallizes.
Example 3. Analogously to Example 1, a mixture of isomers consisting of 20.1% of 9-cis-vitamin A and 67 acetate is obtained from a mixture of 12.5% full trans-vitamin A acetate and 87.5% 9-cis-vitamin A acetate. , 6% complete trans vitamin A, from which practically pure vitamin A acetate can be crystallized
Example 4. Table 1 presents the isomerization results using various catalysts, solvents, temperature, time, and starting products. 5731894 Conditions of use and composition of products 6 Table 1 isomerization
Octadien) PdBr ,,
3523,972,9
120
 (Cycloooctatetraen) RSAH2
) N (Acrylonitol, Ryl) PdCe,.,
(() 2
  Pd (pyridyl), (NO}
eight
731894
Continuation of table 1
15
50 23.7 68.7
15
65 21
73.2
65 18.6 73.7
60
65 18.7 75.2
60
1 mol.%
(S "7), 1 mol.%
78
1808020
79 79
1808017
1808017
()
(C.H) N 1% PdO / NiO 10 mol%
8 h, activated under argon
1 mol%
(C H) N (Ph, P) Pdce2 + 10% by volume
(С Н, Ш (CH ,, CN),
СН-ЗСЫ 4 PdCEj + 10 vol.%
but
(yq Pd (NO),
(cyclooctadiene) PdCGj
 (CH3CN) 2
PdCE2
(C. (Benzonit2 mol. Pyl), Pdce2
(CaH-fjN Pd (NO-) 2 mol.%
() 2 PdCE2
180
80
73
23
65
21
180
80
180
72
80
25
18,275,4
65
CH, CN + 180
19,280,8
50
15
22,277,5
60
65
CH CN
65, 15.683.7
85.0
6515
6522,770.5 5.9
606515,355,8 20
CH CN
606523,967.7 3.5
9-cis-a-apirt
(1,5 cyclooctadie) RdSe2
 ) se
(Benzonitrile) PdCe2 Designations: A - acetate - I, where R is COOCH ,; A is an aldehyde I, where R is CHO; A - alcohol - I, where R - A - acid - I, where R - COOH. The treatment of the resulting mixtures of isomers is carried out analogously to Example 1. and measure 5; 20 g of a mixture of 61% complete trans-, 35.9% acetate 11-cis-, 1.4% acetate 11,13-di-cis-, 1% acetate 9-cis-vitamin A dissolved in a solution of 120 ml acetonitrile — water (90% CHoCN + 10%) and 85 ml of triethyla per (1 mol.% in terms of the mixture of isomers), 159 mg (CH-CN), PdCC2 (1 mol.% in terms of the mixture of isomers) were added. and stirred for 7 hours at 50 ° C. After that, the mixture is extracted 4 times with 120 ml of n-hexane, the extracts are dried over sodium sulfate and evaporated. After drying for 2 hours at a high vacuum at room temperature, 20 are obtained; P g of a mixture containing 69.1% of total trans-, 19% tata 9-cis- and 0.2% acetate 11,13-d-cis acetate -vitamin A. These 20.77 g of mixture are crystallized from 20 ml of n-hexane and 8.56 stock solution is obtained, as well as ll, 0i crystals containing 99, 2% acetaceous full trans and 0.6% acetate 9- qi-vitamin A. 8.56 g of the mother liquor is dissolved in the above isomerization mixture, stirred for one hour at and then extracted and dried as described above, according to 8.4 g of the mixture containing
Continuation of table 1
15 65 23.2 56.2
60 65 17.8 61.5
60 65 18.6 57.2
35 150 18.5 63.1
Nitrobenzene 67.8% acetate full trans- and 20.5% acetate 9-cis-vitamin A. These 8.4 g mixture crystallize from 8.5 ml n-hexane. In this way, another 4.08 g of crystals are obtained, consisting of 99.3% of complete trans-acetate and 0.7 g of 9-cis-vitamin A acetate, as well as 4.22 g of stock solution containing 41.4% of acetate complete trans-, 40.4% acetate 9-cis-, 1.5% acetate 11,13-di-cis-, 0.4% acetate 11-cis- and 0.4% acetate 13-cis-vitamin A, 85 ml of triethylamine are added to the isomerization mixture. 4.22 g of stock solution is dissolved in this solution, stirred for 1 hour and then extracted and dried as described above. 3.68 g of a mixture containing 58.6% of complete trans-, 18% acetate of 9-cis-and 0.6% of 13-cis-vitamin A acetate is obtained. Then, 3.66 g of the mixture is crystallized from, 4 ml of n- hexane, and another 1.5 g of crystals are obtained containing 98.7% of full trans - and 0.5% 9-cis-vitamin A acetate. All analyzes are performed using liquid chromatography. Example 6. Similarly, when-. measure 1 in the manner of full-transvitamin A acetate for 3 hours while in acetonitrile with 10% water is converted into a mixture containing 75% complete trans-vitamin A acetate and 11% 9-cis-vitamin A acetate. The isomerization catalyst consists of 10 mol% palladium on a mixed polymerizate of styrene and divinylbenzene with benzyl diphenylphosphine. Example 7. 1g of 9-cis-vitamin A acetate is dissolved in 5 ml of acetonitrile. After adding 0.5 g of one of the following catalysts:
a) PdO / BaSO;
c) molecular sieve;
c) Pdp / CaSQ (2% palladium on the carrier)
the reaction mixture is heated for 1 hour with stirring. After cooling the reaction mixture, the catalyst was filtered off and the filtrate was evaporated in vacuo at room temperature. The mixture of isomers obtained in each case has the following distribution of components:
a) 72% total trans acetate and 28% 9-cis-vitamin A acetate;
b) 68% complete trans- and 32% acetate 9-cis-vitamin A;
c) 71% total trans acetate acetate 29% 9-cis-vitamin A acetate,
Example 8. 1g of 9-cis -vitamin A acetate is dissolved in 5 ml of acetonitrile. PdO / BaSO catalyst is then added with the palladium concentrations indicated in the table, so that the palladium content in terms of substrate is always -1%. The reaction mixture is heated for 1 hour at 70 ° C with stirring. After cooling, the catalyst is filtered and the filtrate is evaporated in a vacuum. The resulting mixture of vitamin A isomers of acetate has a total acetate content of about 99-100% and isomers distribution indicated in Table 2.
table 2
74 73
26 27
Example 9. 20 g of PdO / BaSOj. Catalyst containing 0.5% palladium on a support are loaded into a glass column heated to 70 s. Through this catalyst filled column 10 g of a mixture of (60:40) 9-cis acetate (complete) -trans-vitamin A, dissolved in 30 ml of acetonitrile. A further 50 ml of acetonitrile is added. After evaporation of the filtrate, 9 g of a mixture of 9-cis- (full) -trans-vitamin A acetate are thus obtained in a ratio of 29:71.
Example 10. A mixture of isomers of 9-cis- (complete) -trans-vitamin A acetate in a ratio of 60:40 is dissolved in 15 ml of a mixture of heptane - acetonitrile in the ratio indicated in Table 3. After adding 6 g of Pdo / BaSO4 d-catalyst with 0.5% palladium on the support, it is heated for 1 hour with stirring. After cooling the reaction mixture, the catalyst is filtered off and the filtrate is evaporated in vacuo. The mixture of vitamin A acetate isomers obtained in each case has the distribution of isomers indicated in the table:
T a b l and c a 3
Example 11. 1 g of 9-cis-vitamin A acetate is dissolved in 5 ml of one of the table. 4 solvents. After adding 2 g of PdO / BaSO4 d-catalyst (0.5% palladium on the support), the reaction mixture is stirred for 1 h at 70 s. After cooling the reaction mixture, the catalyst is filtered off and the filtrate is evaporated, the mixture of isomers of vitamin A acetate obtained in each case has the distribution of isomers given in the table.
Table 4

权利要求:
Claims (2)
[1]
Claims 1. Method for isomerization of vitamin and its derivatives of general formula I
% CH
SI,
sn.
X f
G.GSI CH-С - CH-CH-CH-С CHSn where X is -CHO, -CHj, OR, -COOR; R, -H, -COCH-; R - H, CjHy, characterized in that, in order to increase the yield of the full trans isomer, either complete trans or 9-cis or 11-cis-isomer of vitamin A or its derivatives of formula I, or their mixtures in the presence of a palladium compound, except palladium phthalocyan and palladium compounds containing a cyanide group, in an organic solvent without access to air at 40-1SO C. 2. Method POP.1, characterized in that salts or complexes are used as palladium compounds PdO-Pd (II) -Pd (IV) with or without carrier. 3. The method according to Claim 1, which refers to the fact that the catalyst takes 0.1 to 50 mol.% In terms of the initial one. 4, Method pop., Characterized by the fact that an aprotic polar or non-polar solvent is used as an organic solvent with the addition of 10% water by volume. 5. A process according to claim 1, characterized in that the trialkylamine is used mainly in an amount of 0.1-30 mol.%, Based on the original. Sources of information taken into account in the examination 1.Patent of Germany 1618789, cl. 12 O 25/00, 1972.
[2]
2. The patent of Germany In 2210800, cl. 12 O 25/00, 1973 (prototype).

类似技术:

---

公开号 | 公开日 | 专利标题

---

Fletcher Jr et al.1947|1, 5-Anhydro-xylitol

---

Corey et al.1957|The Synthesis of α-Santalene and of trans-Δ11, 12-Iso-α-santalene

---

SU731894A3|1980-04-30|Method of vitamin a or its derivatives isomerization

---

Kimura et al.1982|Relationship between acidcatalyzed cyclization of citral and deterioration of lemon flavor

---

Naoshima et al.1989|Synthesis of Both the Enantiomers of Phoracantholide I, A Defensive Secretion of the Eucarypt Longicorn |, Employing Microbial Asymmetric Reduction with Immobilized Baker’s Yeast

---

US5198561A|1993-03-30|Ruthenium-BINAP asymmetric hydrogenation catalyst

---

Machiya et al.1985|A convenient synthesis of four stereoisomers of 6-acetoxy-5-hexadecanolide, the major component of the mosquito oviposition attractant pheromone

---

US4748271A|1988-05-31|Process for the preparation of cis-5-fluoro-2-methyl-1-|-indene-3-acetic acid

---

Strekowski et al.1986|Resolution and assignment of absolute configuration to the enantiomers of anastrephin and epianastrephin and their analogs

---

JP3585522B2|2004-11-04|Method for producing 13- | -retinoic acid

---

Birch et al.1981|Organometallic complexes in organic synthesis. Absolute configurations of some simply substituted tricarbonyliron complexes

---

US4026778A|1977-05-31|Photochemical isomerization of vitamin A compounds

---

US4544510A|1985-10-01|Process for preparing cyclopropane carboxylic acid ester derivatives

---

Schwartz et al.1978|Predicting the enantiomeric selectivity of chymotrypsin. Homologous series of ester substances

---

Folsom et al.1992|The Controlled Oxidation of Organic Sulfides to Sulfoxides with the Help of O-Iodosylbenzoic Acid

---

US5689022A|1997-11-18|Preparation of β-carotene products with a high 9 | content

---

US4051174A|1977-09-27|Isomerization process

---

US4345090A|1982-08-17|Process for preparing menthyl esters of enantiomers of chiral 3-|-2,2-dimethylcyclopropanecarboxylic acids

---

Tran et al.1996|Synthesis of |-6-hydroxyshikimic acid from |-5, 6-dihydroxy-1, 3-cyclohexadienyl) methanenitrile

---

Liaaen-Jensen1997|Stereochemical aspects of carotenoids

---

Hedgley et al.1965|Synthesis of a Thionobenzoate in the Polyhydroxytetrahydropyran Series

---

DK170945B1|1996-03-25|Process for Preparation of 13-Cisretinoic Acid and Process for Preparing a Palladium Catalyst for Use in the Process

---

US4233129A|1980-11-11|Process of preparation of alkyl esters of dl cis chrysanthemic acid

---

Miyano et al.1973|Prostaglandins. VI. Correlation of the absolute configuration of pyrethrolone with that of the prostaglandins

---

Lu et al.1994|Construction of α-alkylidene-γ-butyrolactones from acyclic ester precursors

同族专利:

---

公开号 | 公开日

---

FR2245626A1|1975-04-25|

---

GB1452012A|1976-10-06|

---

CH590222A5|1977-07-29|

---

ATA678474A|1979-07-15|

---

DE2439860C3|1980-01-17|

---

AT355231B|1980-02-25|

---

NL7411171A|1975-02-25|

---

NL176259C|1985-03-18|

---

IL45366A|1979-05-31|

---

JPS5613712B2|1981-03-30|

---

FR2245626B1|1978-11-10|

---

JPS5049256A|1975-05-01|

---

ZA744737B|1975-08-27|

---

IL45366D0|1974-10-22|

---

NL176259B|1984-10-16|

---

DD114803A5|1975-08-20|

---

BE819012A|1975-02-20|

---

DE2439860A1|1975-03-06|

---

DE2439860B2|1979-05-23|

---

CS181769B2|1978-03-31|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US5908957A|1997-02-14|1999-06-01|Roche Vitamins Inc.|Isomerization process|

---

KR101710505B1|2009-09-15|2017-02-27|노벨리언 테라퓨틱스 인코포레이티드|Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle|

---

JP6250389B2|2010-04-19|2017-12-20|ノベリオン セラピューティクス インコーポレイテッド|Treatment plan and treatment method for treating or improving visual impairment associated with endogenous retinoid deficiency|

---

DK2819667T3|2012-03-01|2020-03-30|Retinagenix Therapeutics Inc|RETINAL DERIVATIVES TO USE TO IMPROVE THE VISION FUNCTION|

---

CN111233726B|2020-03-26|2021-12-14|万华化学集团股份有限公司|Method for preparing all-trans vitamin A acetate|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

CH1199473A|CH590222A5|1973-08-21|1973-08-21|

---